Genetic variability can significantly impact toxicological pathways. Polymorphisms in genes encoding metabolic enzymes, such as those in the cytochrome P450 family, can lead to variations in the metabolism of drugs and toxicants. These genetic differences explain why some individuals are more susceptible to certain toxicants due to slower or faster metabolism, affecting the toxicological outcomes.
